ALBEMARLE CORP (ALB) Stock Fundamental Analysis

NYSE:ALB • US0126531013

168.42 USD
+0.01 (+0.01%)
At close: Feb 20, 2026
168.425 USD
0.01 (0%)
After Hours: 2/20/2026, 8:16:36 PM
Overview Stock Chart Technical Analysis Fundamental Analysis Analyst Ratings Earnings Estimates Financials Ownership News
Fundamental Rating

4

Overall ALB gets a fundamental rating of 4 out of 10. We evaluated ALB against 83 industry peers in the Chemicals industry. The financial health of ALB is average, but there are quite some concerns on its profitability. ALB is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • ALB had negative earnings in the past year.
  • ALB had a positive operating cash flow in the past year.
  • In multiple years ALB reported negative net income over the last 5 years.
  • ALB had a positive operating cash flow in each of the past 5 years.
ALB Yearly Net Income VS EBIT VS OCF VS FCFALB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

1.2 Ratios

  • The Return On Assets of ALB (-4.14%) is worse than 67.47% of its industry peers.
  • ALB's Return On Equity of -7.11% is on the low side compared to the rest of the industry. ALB is outperformed by 62.65% of its industry peers.
  • ALB's Return On Invested Capital of 0.37% is on the low side compared to the rest of the industry. ALB is outperformed by 77.11% of its industry peers.
Industry RankSector Rank
ROA -4.14%
ROE -7.11%
ROIC 0.37%
ROA(3y)-1.15%
ROA(5y)3.02%
ROE(3y)-1.2%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
ALB Yearly ROA, ROE, ROICALB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20 30

1.3 Margins

  • Looking at the Operating Margin, with a value of 1.34%, ALB is doing worse than 72.29% of the companies in the same industry.
  • In the last couple of years the Operating Margin of ALB has declined.
  • Looking at the Gross Margin, with a value of 13.00%, ALB is doing worse than 78.31% of the companies in the same industry.
  • ALB's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 1.34%
PM (TTM) N/A
GM 13%
OM growth 3Y-63.89%
OM growth 5Y-37.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-32.21%
GM growth 5Y-16.29%
ALB Yearly Profit, Operating, Gross MarginsALB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. Health

2.1 Basic Checks

  • ALB has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
  • Compared to 1 year ago, ALB has about the same amount of shares outstanding.
  • Compared to 5 years ago, ALB has more shares outstanding
  • ALB has a better debt/assets ratio than last year.
ALB Yearly Shares OutstandingALB Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ALB Yearly Total Debt VS Total AssetsALB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • ALB has an Altman-Z score of 2.62. This is not the best score and indicates that ALB is in the grey zone with still only limited risk for bankruptcy at the moment.
  • The Altman-Z score of ALB (2.62) is better than 71.08% of its industry peers.
  • The Debt to FCF ratio of ALB is 4.61, which is a neutral value as it means it would take ALB, 4.61 years of fcf income to pay off all of its debts.
  • ALB's Debt to FCF ratio of 4.61 is amongst the best of the industry. ALB outperforms 83.13% of its industry peers.
  • A Debt/Equity ratio of 0.33 indicates that ALB is not too dependend on debt financing.
  • ALB has a Debt to Equity ratio of 0.33. This is in the better half of the industry: ALB outperforms 72.29% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 4.61
Altman-Z 2.62
ROIC/WACC0.03
WACC14.03%
ALB Yearly LT Debt VS Equity VS FCFALB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B 4B 6B 8B

2.3 Liquidity

  • ALB has a Current Ratio of 2.23. This indicates that ALB is financially healthy and has no problem in meeting its short term obligations.
  • ALB has a better Current ratio (2.23) than 61.45% of its industry peers.
  • A Quick Ratio of 1.57 indicates that ALB should not have too much problems paying its short term obligations.
  • ALB has a Quick ratio of 1.57. This is in the better half of the industry: ALB outperforms 63.86% of its industry peers.
Industry RankSector Rank
Current Ratio 2.23
Quick Ratio 1.57
ALB Yearly Current Assets VS Current LiabilitesALB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an impressive 66.24% over the past year.
  • Looking at the last year, ALB shows a decrease in Revenue. The Revenue has decreased by -4.37% in the last year.
  • The Revenue has been growing by 10.45% on average over the past years. This is quite good.
EPS 1Y (TTM)66.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.38%
Revenue 1Y (TTM)-4.37%
Revenue growth 3Y-11.1%
Revenue growth 5Y10.45%
Sales Q2Q%15.94%

3.2 Future

  • Based on estimates for the next years, ALB will show a very strong growth in Earnings Per Share. The EPS will grow by 105.97% on average per year.
  • ALB is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.88% yearly.
EPS Next Y447.41%
EPS Next 2Y215.54%
EPS Next 3Y127.7%
EPS Next 5Y105.97%
Revenue Next Year9.91%
Revenue Next 2Y9.46%
Revenue Next 3Y8.47%
Revenue Next 5Y14.88%

3.3 Evolution

  • The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
ALB Yearly Revenue VS EstimatesALB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
ALB Yearly EPS VS EstimatesALB Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 10 20 30

More info and screens

Find the best growth stocksShow best growing peers

3

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for ALB. In the last year negative earnings were reported.
  • Based on the Price/Forward Earnings ratio of 61.37, the valuation of ALB can be described as expensive.
  • Based on the Price/Forward Earnings ratio, ALB is valued a bit more expensive than the industry average as 66.27% of the companies are valued more cheaply.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 28.06, ALB is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 61.37
ALB Price Earnings VS Forward Price EarningsALB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 -50 -100 -150 -200

4.2 Price Multiples

  • 78.31% of the companies in the same industry are cheaper than ALB, based on the Enterprise Value to EBITDA ratio.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ALB indicates a somewhat cheap valuation: ALB is cheaper than 62.65% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 28.63
EV/EBITDA 29.42
ALB Per share dataALB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • ALB's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • ALB's earnings are expected to grow with 127.70% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y215.54%
EPS Next 3Y127.7%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

5

5. Dividend

5.1 Amount

  • ALB has a yearly dividend return of 0.96%, which is pretty low.
  • Compared to an average industry Dividend Yield of 2.18, ALB has a dividend in line with its industry peers.
  • Compared to an average S&P500 Dividend Yield of 1.81, ALB's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.96%

5.2 History

  • The dividend of ALB is nicely growing with an annual growth rate of 14.86%!
  • ALB has paid a dividend for at least 10 years, which is a reliable track record.
  • ALB has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)14.86%
Div Incr Years30
Div Non Decr Years30
ALB Yearly Dividends per shareALB Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • The earnings of ALB are negative and hence is the payout ratio. ALB will probably not be able to sustain this dividend level.
  • The dividend of ALB is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-52.74%
EPS Next 2Y215.54%
EPS Next 3Y127.7%
ALB Yearly Income VS Free CF VS DividendALB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B -1B 2B

More info and screens

Find the best dividend stocksShow peers with best dividend

ALBEMARLE CORP

NYSE:ALB (2/20/2026, 8:16:36 PM)

After market: 168.425 0.01 (0%)

168.42

+0.01 (+0.01%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)02-11
Earnings (Next)04-28
Inst Owners96.18%
Inst Owner Change-1.2%
Ins Owners0.36%
Ins Owner Change-3.8%
Market Cap19.82B
Revenue(TTM)5.14B
Net Income(TTM)-677.38M
Analysts74.19
Price Target171.27 (1.69%)
Short Float %7.79%
Short Ratio2.77
Dividend
Industry RankSector Rank
Dividend Yield 0.96%
Yearly Dividend3.04
Dividend Growth(5Y)14.86%
DP-52.74%
Div Incr Years30
Div Non Decr Years30
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)23.68%
Min EPS beat(2)-28.49%
Max EPS beat(2)75.86%
EPS beat(4)3
Avg EPS beat(4)57.57%
Min EPS beat(4)-28.49%
Max EPS beat(4)113.21%
EPS beat(8)3
Avg EPS beat(8)-20.89%
EPS beat(12)6
Avg EPS beat(12)-0.71%
EPS beat(16)10
Avg EPS beat(16)3.12%
Revenue beat(2)2
Avg Revenue beat(2)3.19%
Min Revenue beat(2)1.46%
Max Revenue beat(2)4.93%
Revenue beat(4)3
Avg Revenue beat(4)1.72%
Min Revenue beat(4)-7.88%
Max Revenue beat(4)8.39%
Revenue beat(8)5
Avg Revenue beat(8)0.57%
Revenue beat(12)6
Avg Revenue beat(12)-0.61%
Revenue beat(16)7
Avg Revenue beat(16)-0.65%
PT rev (1m)38.15%
PT rev (3m)74.24%
EPS NQ rev (1m)24.76%
EPS NQ rev (3m)33.52%
EPS NY rev (1m)7.92%
EPS NY rev (3m)47.45%
Revenue NQ rev (1m)0.44%
Revenue NQ rev (3m)2.95%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)1.31%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 61.37
P/S 3.85
P/FCF 28.63
P/OCF 15.46
P/B 2.08
P/tB 2.54
EV/EBITDA 29.42
EPS(TTM)-0.79
EYN/A
EPS(NY)2.74
Fwd EY1.63%
FCF(TTM)5.88
FCFY3.49%
OCF(TTM)10.89
OCFY6.47%
SpS43.69
BVpS81
TBVpS66.44
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -4.14%
ROE -7.11%
ROCE 0.47%
ROIC 0.37%
ROICexc 0.42%
ROICexgc 0.48%
OM 1.34%
PM (TTM) N/A
GM 13%
FCFM 13.46%
ROA(3y)-1.15%
ROA(5y)3.02%
ROE(3y)-1.2%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-69.86%
ROICexgc growth 5Y-39.71%
ROICexc growth 3Y-69.41%
ROICexc growth 5Y-37.84%
OM growth 3Y-63.89%
OM growth 5Y-37.87%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-32.21%
GM growth 5Y-16.29%
F-Score5
Asset Turnover0.31
Health
Industry RankSector Rank
Debt/Equity 0.33
Debt/FCF 4.61
Debt/EBITDA 4.29
Cap/Depr 89.54%
Cap/Sales 11.47%
Interest Coverage 0.38
Cash Conversion 176.29%
Profit Quality N/A
Current Ratio 2.23
Quick Ratio 1.57
Altman-Z 2.62
F-Score5
WACC14.03%
ROIC/WACC0.03
Cap/Depr(3y)292.05%
Cap/Depr(5y)334.21%
Cap/Sales(3y)21.71%
Cap/Sales(5y)22.2%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)66.24%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%51.38%
EPS Next Y447.41%
EPS Next 2Y215.54%
EPS Next 3Y127.7%
EPS Next 5Y105.97%
Revenue 1Y (TTM)-4.37%
Revenue growth 3Y-11.1%
Revenue growth 5Y10.45%
Sales Q2Q%15.94%
Revenue Next Year9.91%
Revenue Next 2Y9.46%
Revenue Next 3Y8.47%
Revenue Next 5Y14.88%
EBIT growth 1Y110.87%
EBIT growth 3Y-67.9%
EBIT growth 5Y-31.38%
EBIT Next Year1566.71%
EBIT Next 3Y231.67%
EBIT Next 5Y126.46%
FCF growth 1Y169.76%
FCF growth 3Y2.33%
FCF growth 5YN/A
OCF growth 1Y86.41%
OCF growth 3Y-12.4%
OCF growth 5Y9.93%

ALBEMARLE CORP / ALB FAQ

What is the ChartMill fundamental rating of ALBEMARLE CORP (ALB) stock?

ChartMill assigns a fundamental rating of 4 / 10 to ALB.


What is the valuation status of ALBEMARLE CORP (ALB) stock?

ChartMill assigns a valuation rating of 3 / 10 to ALBEMARLE CORP (ALB). This can be considered as Overvalued.


What is the profitability of ALB stock?

ALBEMARLE CORP (ALB) has a profitability rating of 1 / 10.


What is the financial health of ALBEMARLE CORP (ALB) stock?

The financial health rating of ALBEMARLE CORP (ALB) is 6 / 10.


What is the earnings growth outlook for ALBEMARLE CORP?

The Earnings per Share (EPS) of ALBEMARLE CORP (ALB) is expected to grow by 447.41% in the next year.